Concepedia

Tseng-hui Timothy Chen

TT

Statistics

Publications

14

Citations

2.5K

H-Index

13

Active since

1984

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Pittsburgh

The University of Texas MD Anderson Cancer Center

Johns Hopkins University

Tseng-hui Timothy Chen is an author at Bristol-Myers Squibb (United States) specializing in oncology, life sciences, and cancer immunotherapy.

ORCID

Publications per year

1984–2022

14

Publications

14

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

M. J. Selby, John Engelhardt, Michael Quigley et al. · Cancer Immunology Research · 2013 · 861 citations

, , +17

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

Joë-Marc Chauvin, Ornella Pagliano, Julien Fourcade et al. · Journal of Clinical Investigation · 2015 · 769 citations · Full text

, , +17

CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45

Robert Halenbeck, H. Robson MacDonald, Anne Roulston et al. · Current Biology · 1998 · 199 citations · Full text

, , +5

Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors

Betty Li, Melinda VanRoey, Changyu Wang et al. · Clinical Cancer Research · 2009 · 188 citations

, , +17

Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer

Theera Umsawasdi, Manuel Valdivieso, Tseng-hui Timothy Chen et al. · Journal of Neuro-Oncology · 1984 · 132 citations

, , +12

1–5 of 14